Track the Cardinal Health share price and the full insider trade history of the company, a listed equity based in United States. Shares are listed on US US, under the oversight of SEC (Form 4). The latest transaction was reported on 8 June 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: Gregory Kenny. All data is accessible without an account.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration
Cardinal Health is an American company that specializes in the distribution of pharmaceuticals and medical devices. It also provides supply chain management services to healthcare institutions.